HIV New Product Introduction Toolkit

Highlights in trends from adult ARV, pediatric ARV, and advanced HIV disease markets with summaries on APWG key performance indicators.

Last Updated: December 21, 2021 Since March 2017, the APWG has been publishing a quarterly rolling forecast for all ARVs (outside of...

Through quarterly order cycles and monthly business calls, the APWG continues to support the ARV market in low-and middle-income...

Keeping an adequate stock of ARVs on hand is important for multiple reasons. Too much stock, and programs run the risk of products...

As national programs continue to rollout new generic ARVs, there is a need for routine, careful monitoring of product uptake to ensure...

Around 37 million individuals are living worldwide with HIV and although advances in therapy have yielded effective regimens, individual...

Forms to be completed at detection of pregnancy and at the end of the pregnancy of a woman living with HIV (delivery, fetal demise or...

This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring...

This Toolkit contains various practical tools and guidance to support countries as they introduce point-of-care (POC) HIV technologies...

A tool to be used at facility-level to track and monitor adverse events related to HIV treatment.

As part of product rollout and monitoring activities, countries must ensure that ordering and management practices at the facility-level...

This three part training course aims to provide Pharmacy Mentors with the knowledge, skills, and attitudes needed to mentor...

The pediatric ARV market, despite growth over the last 10 years, remains relatively small and at risk. To address procurement and access...